DK169305B1 - Anvendelse af propentofyllin og beslægtede forbindelser til fremstilling af et terapeutisk middel til behandling af peptisk ulcus - Google Patents
Anvendelse af propentofyllin og beslægtede forbindelser til fremstilling af et terapeutisk middel til behandling af peptisk ulcus Download PDFInfo
- Publication number
- DK169305B1 DK169305B1 DK520787A DK520787A DK169305B1 DK 169305 B1 DK169305 B1 DK 169305B1 DK 520787 A DK520787 A DK 520787A DK 520787 A DK520787 A DK 520787A DK 169305 B1 DK169305 B1 DK 169305B1
- Authority
- DK
- Denmark
- Prior art keywords
- ulcer
- propentophylline
- treatment
- peptic ulcer
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23607886 | 1986-10-06 | ||
| JP23607886 | 1986-10-06 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK520787D0 DK520787D0 (da) | 1987-10-05 |
| DK520787A DK520787A (da) | 1988-04-07 |
| DK169305B1 true DK169305B1 (da) | 1994-10-10 |
Family
ID=16995393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK520787A DK169305B1 (da) | 1986-10-06 | 1987-10-05 | Anvendelse af propentofyllin og beslægtede forbindelser til fremstilling af et terapeutisk middel til behandling af peptisk ulcus |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4845102A (pt) |
| EP (1) | EP0266559B1 (pt) |
| JP (1) | JPS63225317A (pt) |
| KR (1) | KR950007101B1 (pt) |
| AT (1) | ATE75399T1 (pt) |
| AU (1) | AU595379B2 (pt) |
| CA (1) | CA1297021C (pt) |
| DE (1) | DE3778642D1 (pt) |
| DK (1) | DK169305B1 (pt) |
| ES (1) | ES2032797T3 (pt) |
| GR (1) | GR3004848T3 (pt) |
| HU (1) | HU200098B (pt) |
| IE (1) | IE60863B1 (pt) |
| IL (1) | IL84096A (pt) |
| PT (1) | PT85866B (pt) |
| ZA (1) | ZA877454B (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2661666B2 (ja) * | 1988-02-19 | 1997-10-08 | ヘキスト薬品工業株式会社 | 抗消化性潰瘍剤 |
| DD298051A5 (de) * | 1989-08-16 | 1992-02-06 | ��@���������@�������k�� | Verfahren zur herstellung eines therapeutischen agens zur behandlung von verdauungskrankheiten |
| DE4025371A1 (de) * | 1990-08-10 | 1992-02-13 | Kali & Salz Ag | Verfahren zur reinigung von elektrostatisch gewonnenem steinsalz |
| EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
| US6693105B1 (en) | 1992-11-16 | 2004-02-17 | Cell Therapeutics, Inc. | Hydroxyl-containing compounds |
| US5804584A (en) * | 1992-11-16 | 1998-09-08 | Cell Therapeutics, Inc. | Therapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atoms |
| US20030207901A1 (en) * | 1999-07-27 | 2003-11-06 | Cell Therapeutics, Inc. | Hydroxyl-containing compounds |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| CH608236A5 (pt) * | 1974-01-22 | 1978-12-29 | Wuelfing J A Fa | |
| CA1075690A (en) * | 1974-12-13 | 1980-04-15 | Hoechst Aktiengesellschaft | Xanthine derivatives |
| US4511557A (en) * | 1981-08-24 | 1985-04-16 | Gauri Kailash Kumar | Pharmaceutical composition |
| IT1200944B (it) * | 1982-08-10 | 1989-01-27 | Malesci Sas | Derivati xantinici,procedimento per la loro preparazione,composizione farmaceutiche che il contengono e loro impiego terapeutico |
| US4636507A (en) * | 1984-04-30 | 1987-01-13 | Hoechst-Roussel Pharmaceuticals Inc. | Host defense mechanism enhancement |
-
1987
- 1987-09-24 JP JP62237540A patent/JPS63225317A/ja active Pending
- 1987-10-01 DE DE8787114328T patent/DE3778642D1/de not_active Expired - Fee Related
- 1987-10-01 EP EP87114328A patent/EP0266559B1/en not_active Expired - Lifetime
- 1987-10-01 AT AT87114328T patent/ATE75399T1/de active
- 1987-10-01 ES ES198787114328T patent/ES2032797T3/es not_active Expired - Lifetime
- 1987-10-02 US US07/103,816 patent/US4845102A/en not_active Expired - Fee Related
- 1987-10-05 IL IL84096A patent/IL84096A/xx not_active IP Right Cessation
- 1987-10-05 IE IE265687A patent/IE60863B1/en not_active IP Right Cessation
- 1987-10-05 HU HU874468A patent/HU200098B/hu not_active IP Right Cessation
- 1987-10-05 ZA ZA877454A patent/ZA877454B/xx unknown
- 1987-10-05 AU AU79358/87A patent/AU595379B2/en not_active Ceased
- 1987-10-05 CA CA000548615A patent/CA1297021C/en not_active Expired - Lifetime
- 1987-10-05 DK DK520787A patent/DK169305B1/da not_active IP Right Cessation
- 1987-10-06 PT PT85866A patent/PT85866B/pt not_active IP Right Cessation
- 1987-10-06 KR KR1019870011129A patent/KR950007101B1/ko not_active IP Right Cessation
-
1992
- 1992-06-05 GR GR920401188T patent/GR3004848T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA877454B (en) | 1988-05-25 |
| JPS63225317A (ja) | 1988-09-20 |
| PT85866B (pt) | 1990-07-31 |
| ES2032797T3 (es) | 1993-03-01 |
| HUT46214A (en) | 1988-10-28 |
| DK520787A (da) | 1988-04-07 |
| PT85866A (en) | 1987-11-01 |
| IE872656L (en) | 1988-04-06 |
| US4845102A (en) | 1989-07-04 |
| GR3004848T3 (pt) | 1993-04-28 |
| EP0266559A2 (en) | 1988-05-11 |
| IL84096A0 (en) | 1988-03-31 |
| IE60863B1 (en) | 1994-08-24 |
| EP0266559B1 (en) | 1992-04-29 |
| ATE75399T1 (de) | 1992-05-15 |
| KR950007101B1 (ko) | 1995-06-30 |
| AU7935887A (en) | 1988-04-14 |
| AU595379B2 (en) | 1990-03-29 |
| HU200098B (en) | 1990-04-28 |
| DE3778642D1 (de) | 1992-06-04 |
| IL84096A (en) | 1991-07-18 |
| DK520787D0 (da) | 1987-10-05 |
| CA1297021C (en) | 1992-03-10 |
| EP0266559A3 (en) | 1990-06-06 |
| KR880004810A (ko) | 1988-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0651642A1 (en) | Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity | |
| JPH0621070B2 (ja) | ジアゼピン含有医薬組成物 | |
| WO2021135654A1 (zh) | 双硫仑在制备防治nlrp3炎症小体相关疾病的药物中的应用 | |
| DK169305B1 (da) | Anvendelse af propentofyllin og beslægtede forbindelser til fremstilling af et terapeutisk middel til behandling af peptisk ulcus | |
| CZ301499B6 (cs) | Lék pro lécbu vysokého krevního tlaku | |
| JP2526059B2 (ja) | 抗潰瘍剤 | |
| US6710046B1 (en) | Pharmaceutical composition for modulating immunity | |
| EA007952B1 (ru) | Применение ирбесартана для изготовления лекарств, которые пригодны для предупреждения или лечения лёгочной артериальной гипертензии | |
| NZ189159A (en) | Oral antihypertensive compositions containing proline derivatives | |
| JP2665357B2 (ja) | 心不全治療用医薬組成物 | |
| EP1687006B1 (en) | Pharmaceutical compositions for the treatment of renal dysfunction | |
| AU7490096A (en) | Treatment of traumatic brain injury | |
| JPH0352816A (ja) | 腎炎の治療剤 | |
| AU624987B2 (en) | Therapeutic agents for the treatment of peptic ulcer disease | |
| US5030630A (en) | Use of 6-allyl-2-amino-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepine- for treating diseases caused by reduced secretion of growth hormone | |
| Llupià et al. | Comparative antiallergic effects of second-generation H1-antihistamines ebastine, cetirizine and loratadine in preclinical models | |
| WO1990007332A1 (en) | Immunosuppressive agent | |
| JP2681085B2 (ja) | 胃炎治療剤 | |
| JP4426654B2 (ja) | 免疫調節用医薬組成物 | |
| JPH0446124A (ja) | 抗潰瘍剤 | |
| JP2548223B2 (ja) | 腎臓疾患治療剤 | |
| JPH035425A (ja) | 抗潰瘍剤 | |
| JP3254712B2 (ja) | 医薬組成物 | |
| KR960014874B1 (ko) | 요산 배출용 조성물 | |
| EP0521381A1 (en) | Use of 3-pyridazinone compounds to reduce blood platelet count |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |